Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1553-1559

  Picci, P ^a   Bohling T ^a   Bacci, G ^a   Ferrari, S ^a   Sangiorgi, L ^a   Mercuri, M ^a   Ruggieri, P ^a   Manfrini, M ^a   Ferraro, A ^a   Casadei, R ^a   Benassi, M S ^a   Mancini, A F ^a   Rosito, P ^a   Cazzola, A ^a   Barbieri, E ^a   Tienghi, A ^a   Brach del Prever, A ^a   Comandone, A ^a   Bacchini, P ^a   Bertoni, F ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; EWING SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR NECROSIS; TUMOR VOLUME;

EID: 0343765723     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1553     Document Type: Article

References (27)

1. O'Connor MI, Pritchard DJ: Ewing's sarcoma. Prognostic factors, disease control, and the reemerging role of surgical treatment. Clin Orthop 262:78-87, 1991
2. Hartman KR, Triche TJ, Kinsella TJ, et al: Prognostic value of histopathology in Ewing's sarcoma, Long-term follow-up of distal extremity primary tumors. Cancer 67:163-171, 1991
3. George E, Niehans GA, Swanson PE, et al: Overexpression of the c-erbB-2 oncogene in sarcomas and small sound-cell tumors of childhood. An immunohistochemical investigation. Arch Pathol Lab Med 116:1033-1035, 1992
4. Dierick AM, Langlois M, Van Oostveldt P, et al: The prognostic significance of the DNA content in Ewing's sarcoma: A retrospective cytomorphometric and flow cytometric study. Histopathology 23:333-339, 1993
5. Aryee DN, Strobel T, Kos K, et al: High nm23-H1/NDPK-A expression in Ewing tumors: Paradoxical immunohistochemical reactivity and lack of prognostic significance. Int J Cancer 21:104-111, 1995
6. Terrier P, Henry-Amar M, Triche TJ, et al: Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis? Eur J Cancer 31A:307-314, 1995
7. Marcus RB, Cantor A, Heare TC, et al: Local control and function after twice-a-day radiotherapy for Ewing's sarcoma of bone. J Int Radiat Oncol Biol Phys 21:1509-1515, 1991
8. Sailer SL, Harmon DC, Mankin HJ, et al: Ewing's sarcoma: Surgical resection as a prognostic factor. Int J Radiat Oncol Biol Phys 15:43-52, 1988
9. Bacci G, Toni A, Avella M, et al: Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 63:1477-1486, 1989
10. Scully SP, Temple HT, O'Keefe RJ, et al: Role of surgical resection in pelvic Ewing's sarcoma. J Clin Oncol 13:2336-2341, 1995
11. Picci P, Bacci G, Campanacci M, et al: Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Cancer 56:1515-1521, 1985
12. Picci P, Rougraff BT, Bacci G, et al: Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol 11:1763-1769, 1993
13. van der Woude HJ, Bloem JL, Taminiau AH, et al: Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone. Skeletal Radiol 23:501-507, 1994
14. Goebel V, Jürgens H, Etspuler G, et al: The prognostic significance of tumor size in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 113:187-191, 1987
15. Jürgens H, Exner U, Gadner H, et al: Multidisciplinary treatment of primary Ewing's sarcoma of bone - A 6-year experience of a European cooperative trial. Cancer 61:23-32, 1988
16. Enneking WF, Spanier SS, Goodman MA, et al: The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg (Am) 62:1027-1030, 1980
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
19. Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly censored samples. Biometrika 52:203-223, 1965
20. Tarone RE, Ware J: On distribution-free tests for equality of survival distributions. Biometrika 64:156-160, 1977
21. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-202, 1972
22. Kushner BH, Meyers PA, Gerald WL, et al: Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol 13:2796-2804, 1995
23. Ladenstein R, Lasset C, Pinkerton R, et al: Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: A report from the EBMT solid tumour registery. Bone Marrow Transplant 15:697-705, 1995
24. Fletcher BD: Response of osteosarcoma and Ewing's sarcoma to chemotherapy: imaging evaluation. AJR 157:825-833, 1991
25. MacVicar AD, Olliff JF, Pringle J, et al: Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation. Radiology 184:859-864, 1992
26. Lang P, Grampp S, Vahlensieck M, et al: Primary bone tumors: Value of MR angiography for preoperative planing and monitoring response to chemotherapy. AJR 165:135-142, 1995
27. Hayes FA, Thompson EI, Meyer WH, et al: Therapy for localized Ewing's sarcoma of bone. J Clin Oncol 7:208-213, 1989